{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:24:53Z","timestamp":1794983093468,"version":"4.9.1"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cirrhotic cardiomyopathy (CCM) is a prevalent yet frequently underrecognized cardiac complication of liver cirrhosis, characterized by impaired myocardial contractile reserve, diastolic dysfunction, and electrophysiological abnormalities. Despite its clinical significance, particularly in the setting of liver transplantation, CCM remains largely overlooked. We performed a narrative review of the literature on CCM published up to December 2025, covering pathophysiology, diagnostic criteria, imaging modalities, biomarkers, and management strategies. Depending on the diagnostic criteria used, the prevalence of CCM ranges from 29% to 67.2%. Advanced imaging techniques, particularly global longitudinal strain and cardiac magnetic resonance, enable early detection of subclinical systolic dysfunction. A \u201ctoxic triangle\u201d comprising systemic inflammation, metabolic derangements, and neurohormonal activation represents an integrated pathophysiological model that drives myocardial fibrosis and dysfunction. Beta-blockers and aldosterone antagonists remain mainstays of pharmacological management, while liver transplantation is currently the only definitive therapy. CCM is an underrecognized condition with substantial clinical implications. Standardized diagnostic criteria, validated biomarkers, and large-scale prospective studies are urgently needed to improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051200","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:01:48Z","timestamp":1792173708000},"page":"e51200","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cirrhotic cardiomyopathy"],"prefix":"10.1097","volume":"105","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Jiujiang No. 1 People\u2019s Hospital, Jiujiang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5823-3032","authenticated-orcid":false,"given":"Jing","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No. 1 People\u2019s Hospital, Jiujiang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis.","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"2328521","DOI":"10.1080\/07853890.2024.2328521","article-title":"Global burden of liver cirrhosis 1990-2019 and 20 years forecast: results from the global burden of disease study 2019.","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2023.5997","article-title":"Diagnosis and management of cirrhosis and its complications: a review.","volume":"329","author":"Tapper","year":"2023","journal-title":"JAMA"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions.","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update.","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"R6-20261118","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2020.11.042","article-title":"The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs.","volume":"75","author":"Jepsen","year":"2021","journal-title":"J Hepatol"},{"key":"R7-20261118","first-page":"530","article-title":"Cardiac abnormalities in liver cirrhosis.","volume":"151","author":"Lee","year":"1989","journal-title":"West J Med"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.510240226","article-title":"Cirrhotic cardiomyopathy: getting to the heart of the matter.","volume":"24","author":"Ma","year":"1996","journal-title":"Hepatology"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","article-title":"Cirrhotic cardiomyopathy.","volume":"53","author":"M\u00f8ller","year":"2010","journal-title":"J Hepatol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era.","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.26000","article-title":"Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria.","volume":"27","author":"Izzy","year":"2021","journal-title":"Liver Transpl"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.14769","article-title":"The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria.","volume":"41","author":"Razpotnik","year":"2021","journal-title":"Liver Int"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5114\/ceh.2021.108708","article-title":"Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification.","volume":"7","author":"Cesari","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.14309\/ajg.0000000000000786","article-title":"Hyponatremia in cirrhosis: an update.","volume":"115","author":"Alukal","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apt.15812","article-title":"Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy.","volume":"52","author":"Wiese","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.arcmed.2020.11.004","article-title":"Myocardial dysfunction in cirrhotic cardiomyopathy is associated with alterations of phospholamban phosphorylation and il-6 levels.","volume":"52","author":"Gregolin","year":"2021","journal-title":"Arch Med Res"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"119261","DOI":"10.1016\/j.lfs.2021.119261","article-title":"Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats.","volume":"273","author":"Esmaeili","year":"2021","journal-title":"Life Sci"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"100911","DOI":"10.1016\/j.jhepr.2023.100911","article-title":"Cardiomyopathy in cirrhosis: from pathophysiology to clinical care.","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/liv.15714","article-title":"Left atrial strain and ventricular global longitudinal strain in cirrhotic patients using the new criteria of cirrhotic cardiomyopathy consortium.","volume":"43","author":"Skouloudi","year":"2023","journal-title":"Liver Int"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1111\/ajt.17049","article-title":"Management of cardiac diseases in liver transplant recipients: comprehensive review and multidisciplinary practice-based recommendations.","volume":"22","author":"Izzy","year":"2022","journal-title":"Am J Transplant"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"120906","DOI":"10.1016\/j.biomaterials.2021.120906","article-title":"Therapies to prevent post-infarction remodelling: from repair to regeneration.","volume":"275","author":"Contessotto","year":"2021","journal-title":"Biomaterials"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure.","volume":"119","author":"Da Dalt","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tem.2023.10.004","article-title":"Lipid metabolism reprogramming in cardiac fibrosis.","volume":"35","author":"Lin","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41522-022-00352-6","article-title":"Host-microbiome interactions: gut-liver axis and its connection with other organs.","volume":"8","author":"Anand","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardiores.2004.02.005","article-title":"Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure.","volume":"63","author":"Sekiguchi","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.3390\/cells11233783","article-title":"Current perspectives of neuroendocrine regulation in liver fibrosis.","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apt.16305","article-title":"Review article: comprehensive analysis of cirrhotic cardiomyopathy.","volume":"53","author":"Chahal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10741-025-10500-7","article-title":"Cirrhotic cardiomyopathy: comprehensive insights into pathophysiology, diagnosis, and management.","volume":"30","author":"Ndakotsu","year":"2025","journal-title":"Heart Fail Rev"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jceh.2021.08.016","article-title":"Diagnosis and management of cirrhotic cardiomyopathy.","volume":"12","author":"Kaur","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"849","DOI":"10.5009\/gnl210537","article-title":"Prolonged QT interval in cirrhosis: twisting time?","volume":"16","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic cardiomyopathy.","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/00365521.2021.1901307","article-title":"Prolonged QTc interval predicts long-term mortality in cirrhosis: a propensity score matching analysis.","volume":"56","author":"Li","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jgh.15179","article-title":"Markedly prolonged QTc interval in end-stage liver disease and risk of 30-day cardiovascular event after liver transplant.","volume":"36","author":"Kim","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cgh.2018.12.006","article-title":"Development and validation of a scoring system that includes corrected QT interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding.","volume":"17","author":"Biselli","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12664-022-01277-w","article-title":"Evaluation of subclinical left ventricular systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with Child-Pugh A and B cirrhosis: a case-control study.","volume":"41","author":"Poojary","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"e0269691","DOI":"10.1371\/journal.pone.0269691","article-title":"Evaluation of subclinical ventricular systolic dysfunction assessed using global longitudinal strain in liver cirrhosis: a systematic review, meta-analysis, and meta-regression.","volume":"17","author":"Ridjab","year":"2022","journal-title":"PLoS One"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3748\/wjg.v25.i32.4779","article-title":"Liver cirrhosis and left ventricle diastolic dysfunction: systematic review.","volume":"25","author":"Stundiene","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3390\/jcm13185442","article-title":"The interplay between severe cirrhosis and heart: a focus on diastolic dysfunction.","volume":"13","author":"Lupu","year":"2024","journal-title":"J Clin Med"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/LVT.0000000000000458","article-title":"The clinical relevance of the new criteria for cirrhotic cardiomyopathy and future directions.","volume":"31","author":"Myers","year":"2025","journal-title":"Liver Transpl"},{"key":"R40-20261118","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/jcm8122132","article-title":"Cardiac imaging in liver transplantation candidates: current knowledge and future perspectives.","volume":"8","author":"Dimitroglou","year":"2019","journal-title":"J Clin Med"},{"issue":"1 Pt 2","key":"R41-20261118","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2019.02.031","article-title":"CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives.","volume":"13","author":"Chamsi-Pasha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/liv.13870","article-title":"Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome.","volume":"38","author":"Wiese","year":"2018","journal-title":"Liver Int"},{"key":"R43-20261118","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.amjcard.2023.09.069","article-title":"Comparison of the 2005 montreal criteria and the 2019 cirrhotic cardiomyopathy consortium criteria for the diagnosis of cirrhotic cardiomyopathy.","volume":"208","author":"Luo","year":"2023","journal-title":"Am J Cardiol"},{"key":"R44-20261118","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/CIRCULATIONAHA.120.046947","article-title":"Markers of myocardial stress, myocardial injury, and subclinical inflammation and the risk of sudden death.","volume":"142","author":"Everett","year":"2020","journal-title":"Circulation"},{"key":"R45-20261118","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/liv.12428","article-title":"Cardiac and proinflammatory markers predict prognosis in cirrhosis.","volume":"34","author":"Wiese","year":"2014","journal-title":"Liver Int"},{"key":"R46-20261118","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension.","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"R47-20261118","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids.","volume":"53","author":"Yang","year":"2010","journal-title":"J Hepatol"},{"key":"R48-20261118","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/CS20130642","article-title":"Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice.","volume":"127","author":"Nam","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"R49-20261118","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.dld.2012.06.020","article-title":"Protective effects of erythropoietin on cirrhotic cardiomyopathy in rats.","volume":"44","author":"Liu","year":"2012","journal-title":"Dig Liver Dis"},{"key":"R50-20261118","doi-asserted-by":"crossref","first-page":"120966","DOI":"10.1016\/j.lfs.2022.120966","article-title":"Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats.","volume":"308","author":"Niaz","year":"2022","journal-title":"Life Sci"},{"key":"R51-20261118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jjcc.2023.04.007","article-title":"Cirrhotic cardiomyopathy: predictors of major adverse cardiac events and assessment of reversibility after liver transplant.","volume":"82","author":"Ali","year":"2023","journal-title":"J Cardiol"},{"key":"R52-20261118","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijcard.2020.11.017","article-title":"Effect of liver transplantation on QT-interval prolongation and impact on mortality.","volume":"326","author":"Ko","year":"2021","journal-title":"Int J Cardiol"},{"key":"R53-20261118","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.3748\/wjg.v20.i42.15492","article-title":"Cirrhotic cardiomyopathy: a cardiologist\u2019s perspective.","volume":"20","author":"Gassanov","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R54-20261118","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.30040","article-title":"Cirrhotic cardiomyopathy after transplantation: neither the transient nor innocent bystander.","volume":"68","author":"Izzy","year":"2018","journal-title":"Hepatology"},{"key":"R55-20261118","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation.","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J Hepatol"},{"key":"R56-20261118","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12664-020-01083-2","article-title":"Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.","volume":"39","author":"Kapoor","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"R57-20261118","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/liv.15896","article-title":"Cardiac dysfunction in patients with cirrhosis and acute decompensation.","volume":"44","author":"Gananandan","year":"2024","journal-title":"Liver Int"},{"key":"R58-20261118","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ahj.2023.04.005","article-title":"Left ventricular remodeling in end-stage liver disease and post-transplant mortality assessed using end-diastolic pressure-volume relation analysis: observational retrospective study.","volume":"262","author":"Shin","year":"2023","journal-title":"Am Heart J"},{"key":"R59-20261118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1665-2681(19)31389-4","article-title":"Impact of the severity of end-stage liver disease in cardiac structure and function.","volume":"12","author":"Silvestre","year":"2013","journal-title":"Ann Hepatol"},{"key":"R60-20261118","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL clinical practice guidelines on liver transplantation.","volume":"81","year":"2024","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:00:47Z","timestamp":1794981647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051200"}},"subtitle":["A comprehensive review of pathophysiology, diagnosis, and management"],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":60,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051200","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2026-07-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}